ClinicalTrials.gov
public full text
Public Domain
SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access
SPECTAmel is a standardized, quality-assured molecular screening platform for tumor characterization and storage of human biological material (HBM) for the purpose of integrating new biomarkers into clinical trials and optimizing access of patients to therapeutic biomarker-driven clinical trials. HBM and clinical/pathological data are collected from consenting patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Biomarker Screening Protocol for Participants With Solid Tumors#184830
- The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy#882219
- Upregulation of <i>RPLP1</i> in PBMCs as a screening biomarker for melanoma#285426
- Vemurafenib Plus Cobimetinib in Metastatic Melanoma#467583
- Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012#833789
Record · ID 1102527
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive